insulin aspart injection

FDA Drug Profile — Fiasp

insulin aspart injection is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Fiasp. Available dosage form: injection, solution.

Drug Details

Generic Name
insulin aspart injection
Brand Names
Fiasp
Application Number
BLA208751
Sponsor
Novo Nordisk
NDC Codes
3
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
INSULIN ASPART

Indications and Usage

1 INDICATIONS AND USAGE FIASP is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. • FIASP is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus ( 1 ).